Projects per year
Search results
-
Active
Improving safety and access to immune effector cell therapy with artificial intelligence technology???
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/24 → 1/31/26
Project: Research project
-
FT522-101: A Phase I Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory B-Cell Lymphoma
5/17/23 → 5/31/28
Project: Research project
-
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
Wagner, J. E., Bachanova, V., Betts, B., Brunstein, C. G., Cichocki, F. M., De For, T. E., Eaton, A., Hippen, K. L., Luo, X., Maakaron, J., McKenna, D. H. & Tolar, J.
NIH NATIONAL CANCER INSTITUTE (NCI)
5/5/23 → 4/30/28
Project: Research project
-
NK cells, their receptors, and cancer therapy
Miller, J. S., Bachanova, V., Basu, S., Brunstein, C. G., Cichocki, F. M., Felices, M., Geller, M. A., Grzywacz, B. J., Le, C. T., Luo, X., Starr, T., Walcheck, B., Warlick, E. D. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/9/21 → 3/31/26
Project: Research project
-
-
A PHASE 1, OPEN-LABEL, MULTI-CENTER, DOSE ESCALATION AND DOSEEXPANSION STUDY OF NKTR-255 AS A SINGLE AGENT IN RELAPSED OR REFRACTORYHEMATOLOGICAL MALIGNANCIES AND IN COMBINATION WITH DARATUMUMAB AS A SALVAGEREGIMEN FOR MULTIPLE MYELOMA
Bachanova, V. & Janakiram, M.
12/2/19 → 12/31/24
Project: Research project
-
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells
3/1/19 → 2/28/35
Project: Research project
-
Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Hodgkin's LymphomaHodgkin???s Lymphoma
8/16/18 → 8/15/28
Project: Research project
-
-
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus
MILLENNIUM PHARMACEUTICALS, INC.
12/1/12 → 3/28/30
Project: Research project